A new study has reported a molecular signature of T-cell-mediated rejection in human kidney transplant biopsy samples that is enriched for effector T cells, interferon-γ and macrophages. Inhibitors of T-cell activation, such as CTLA4 and PDL1, were also prominent, raising the possibility that these immunological constrains could be harnessed by therapies for treating rejection.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model
Scientific Reports Open Access 22 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Venner, J. M. et al. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.12946.
Lefaucheur, C. et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 381, 313–319 (2013).
Racusen, L. C. et al. Antibody-mediated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection. Am. J. Transplant. 3, 708–714 (2003).
Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am. J. Transplant. 13, 2865–2874 (2013).
Liarski, V. M. et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl. Med. 6, 230ra46 (2014).
Reeve, J. et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am. J. Transplant. 13, 645–655 (2013).
Liu, Z., Fan, H. & Jiang, S. CD4+ T-cell subsets in transplantation. Immunol. Rev. 252, 183–191 (2013).
Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227–242 (2013).
De Calisto, J. et al. SAP-dependent and -independent regulation of innate T cell development involving SLAMF receptors. Front. Immunol. 5, 186 (2014).
Chan, C. J. et al. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 15, 431–438 (2014).
Acknowledgements
The work of A.S.C. is supported in part by grants from NIAID and NIH (R01AI110513 and P01AI097113).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Chong, A., Perkins, D. Molecular phenotyping of T-cell-mediated rejection. Nat Rev Nephrol 10, 678–680 (2014). https://doi.org/10.1038/nrneph.2014.197
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.197
This article is cited by
-
Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model
Scientific Reports (2022)
-
The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria
Inflammation Research (2016)